da-5222
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 21, 2025 (NCT06993168)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07046715 | Phase 1 | Jul 7, 2025 | Dong-A Pharmaceutical |
| NCT06993181 | Phase 1 | Jun 30, 2025 | Dong-A Pharmaceutical |
| NCT06993168 | Phase 1 | May 21, 2025 | Dong-A Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dong-A Pharmaceutical | For profit | 3 | 3 | 1 | 2025 |
1 organizations
Page 1 / 1